Source: Health Canada shortage reports · Updated Sep 29, 2026
Travoprost is in a widespread shortage in Canada. 3 of 6 reported products are affected. The latest manufacturer estimate for full recovery is Oct 23, 2026.
A prostaglandin eye drop used to lower eye pressure in glaucoma.
Products affected
3 / 6
In shortage since
Dec 9, 2019
Est. full return
Oct 23, 2026
Reports on file
30
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP TRAVOPROST Z
0.004% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02548089 · since Sep 15, 2026, est. end Oct 23, 2026 · Demand increase for the drug.
Active shortage
SANDOZ TRAVOPROST
0.004% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02413167 · since Jul 13, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-TRAVOPROST Z
0.004% · SOLUTION · APOTEX INC
DIN 02415739 · since Dec 9, 2019, no end estimate · Disruption of the manufacture of the drug.
DIN 02318008 · ended Jan 11, 2023 · Delay in shipping of the drug.
Showing 12 of 30 reports. All reports are on file with Health Canada.
What's happening
Travoprost is currently affected by 3 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, SANDOZ CANADA INCORPORATED, APOTEX INC.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Travoprost is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01EE).
Recent changes
Sep 25, 2026
New report filed
Sep 22, 2026
New report filed
Aug 31, 2026
New report filed
Aug 31, 2026
New report filed
Aug 31, 2026
Estimated end date pushed back : Aug 28, 2026 → Sep 18, 2026
Aug 24, 2026
Estimated end date pushed back : Aug 21, 2026 → Aug 28, 2026
Jul 20, 2026
Status changed
Jul 20, 2026
Estimated end date pushed back : Jul 31, 2026 → Aug 21, 2026
Jul 13, 2026
New report filed
Common questions
What is Travoprost used for?
A prostaglandin eye drop used to lower eye pressure in glaucoma.
When will Travoprost be back in stock in Canada?
The latest manufacturer estimate is Oct 23, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Travoprost in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.